Omalizumab-treated severe allergic asthmatics have comparable small airways function to healthy controls.
H. Kalsi (London, United Kingdom), A. Hakim (London, United Kingdom), S. Meah (London, United Kingdom), P. Paredi (London, United Kingdom), M. Biddiscombee (London, United Kingdom), O. Usmani (London, United Kingdom)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4314
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Kalsi (London, United Kingdom), A. Hakim (London, United Kingdom), S. Meah (London, United Kingdom), P. Paredi (London, United Kingdom), M. Biddiscombee (London, United Kingdom), O. Usmani (London, United Kingdom). Omalizumab-treated severe allergic asthmatics have comparable small airways function to healthy controls.. 4314
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|